DOX — Amdocs Cashflow Statement
0.000.00%
- $9.12bn
- $9.47bn
- $5.00bn
- 91
- 67
- 73
- 91
Annual cashflow statement for Amdocs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 498 | 688 | 550 | 543 | 496 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 42.6 | -170 | 65.1 | 93 | 111 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -111 | 249 | -79.1 | 51.1 | -30 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 658 | 926 | 757 | 823 | 724 |
| Capital Expenditures | -206 | -210 | -227 | -124 | -105 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -256 | -119 | -35.3 | -100 | -21.9 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -462 | -329 | -263 | -224 | -127 |
| Financing Cash Flow Items | -1.65 | -2.52 | -18.3 | -11.1 | -22.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 315 | -871 | -630 | -651 | -771 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 512 | -274 | -136 | -53.3 | -174 |